NEW YORK (GenomeWeb News) — OncoMethylome Sciences has raised €8.4 million ($11.6 million) by selling 1.3 million new shares at €6.29 a share to three investors in a private placement, the cancer biomarker company said today.
The company plans to use the funding to continue to develop biomarkers for use in companion diagnostic tests, cancer detection, and treatment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.